| Literature DB >> 26614035 |
Hui Ling1, Lisa Krassnig2, Marc D Bullock1, Martin Pichler3.
Abstract
Testicular cancer processes a unique and clear miRNA expression signature. This differentiates testicular cancer from most other cancer types, which are usually more ambiguous when assigning miRNA patterns. As such, testicular cancer may represent a unique cancer type in which miRNAs find their use as biomarkers for cancer diagnosis and prognosis, with a potential to surpass the current available markers usually with low sensitivity. In this review, we present literature findings on miRNAs associated with testicular cancer, and discuss their potential diagnostic and prognostic values, as well as their potential as indicators of drug response in patients with testicular cancer.Entities:
Keywords: Biomarkers; Detection; MicroRNA; Prognosis; Testicular cancer
Mesh:
Substances:
Year: 2016 PMID: 26614035 DOI: 10.1016/j.ucl.2015.08.013
Source DB: PubMed Journal: Urol Clin North Am ISSN: 0094-0143 Impact factor: 2.241